17 alpha-Hydroxyprogesterone Caproate for the Prevention of Adverse Neonatal Outcome in Multiple Pregnancies

Arianne C. Lim, Ewoud Schuit, Kitty Bloemenkamp, Rob E. Bernardus, Johannes J. Duvekot, Jan Jaap H. M. Erwich, Jim van Eyck, Rolf H. H. Groenwold, Tom H. M. Hasaart, Piet Hummel, Michael M. Kars, Anneke Kwee, Charlotte M. van Oirschot, Marielle G. van Pampus, Dimitri N. M. Papatsonis, Martina Porath, Marc E. Spaanderman, Christine Willekes, Janine Wilpshaar, Ben W. J. MolHein W. Bruinse

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)513-520
JournalObstetrics and Gynecology
Volume118
Issue number3
DOIs
Publication statusPublished - Sep 2011

Cite this

Lim, A. C., Schuit, E., Bloemenkamp, K., Bernardus, R. E., Duvekot, J. J., Erwich, J. J. H. M., van Eyck, J., Groenwold, R. H. H., Hasaart, T. H. M., Hummel, P., Kars, M. M., Kwee, A., van Oirschot, C. M., van Pampus, M. G., Papatsonis, D. N. M., Porath, M., Spaanderman, M. E., Willekes, C., Wilpshaar, J., ... Bruinse, H. W. (2011). 17 alpha-Hydroxyprogesterone Caproate for the Prevention of Adverse Neonatal Outcome in Multiple Pregnancies. Obstetrics and Gynecology, 118(3), 513-520. https://doi.org/10.1097/AOG.0b013e31822ad6aa